Koebnerisin (S100A15): A novel player in the pathogenesis of rosacea - 16/05/19
Doi : 10.1016/j.jaad.2018.06.012
Aleksandra Batycka-Baran, PhD a, b, Eva Hattinger, BS a, Aleksander Marchenkov, BS a, Maria Koziol, PhD b, Andrzej Bieniek, MD, PhD b, Jacek Szepietowski, MD, PhD b, Thomas Ruzicka, MD, PhD a, Ronald Wolf, MD, PhD a, ⁎ 
a Department of Dermatology and Allergology, Ludwig Maximilian University Munich, Munich, Germany
b Department of Dermatology, Venereology and Allergy, Wroclaw Medical University, Wroclaw, Poland
∗Correspondence to: Ronald Wolf, MD, PhD, Department of Dermatology and Allergology, Frauenlobstrasse 9-11, Munich D-80337, GermanyDepartment of Dermatology and AllergologyFrauenlobstrasse 9-11MunichD-80337Germany
| Funding sources: Supported by grants from Else Kröner-Fresenius-Stiftung (2012_A294 to Dr Wolf) and Wroclaw Medical University (ST-132). |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2018
Publié par Elsevier Masson SAS.
Vol 80 - N° 6
P. 1753-1755 - juin 2019 Retour au numéro
Article précédent
- The uses of naltrexone in dermatologic conditions
- Brigette Lee, Dirk M. Elston
- Pigmentation of basal cell carcinoma is inversely associated with tumor aggressiveness in Asian patients
- Hye-Rim Moon, Tae Jun Park, Ki Woong Ro, Hwa Jung Ryu, Soo Hong Seo, Sang Wook Son, Il-Hwan Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?